March 24, 2020 / 12:48 PM / 7 days ago

BRIEF-Arch Biopartners Discloses New Patent Filing For Novel Drug Candidates To Prevent Lung Inflammation

March 24 (Reuters) - Arch Biopartners Inc:

* ARCH BIOPARTNERS DISCLOSES NEW PATENT FILING FOR NOVEL DRUG CANDIDATES TO PREVENT LUNG INFLAMMATION

* ARCH BIOPARTNERS - EVALUATING POSSIBILITIES TO USE METABLOK IN PHASE II TRIAL FOR LUNG INFLAMMATION DUE TO VIRAL PNEUMONIA IN COVID-19 INFECTED PATIENTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below